In the last trading session, 1.58 million shares of the Vaxart Inc (NASDAQ:VXRT) were traded, and its beta was 0.67. Most recently the company’s share price was $0.62, and it changed around $0.01 or 1.64% from the last close, which brings the market valuation of the company to $141.03M. VXRT currently trades at a discount to its 52-week high of $1.54, offering almost -148.39% off that amount. The share price’s 52-week low was $0.52, which indicates that the current value has risen by an impressive 16.13% since then. We note from Vaxart Inc’s average daily trading volume that its 10-day average is 1.98 million shares, with the 3-month average coming to 1.74 million.

Vaxart Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 6 analysts rate the stock as a Sell; another 2 rate it as Overweight. Among the rest, 0 recommended VXRT as a Hold, whereas 4 deemed it a Buy, and 0 rated it as Underweight. Vaxart Inc is expected to report earnings per share of -0.11 for the current quarter.

Vaxart Inc (NASDAQ:VXRT) trade information

Instantly VXRT has showed a green trend with a performance of 1.64% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 0.7500 on recent trading dayincreased the stock’s daily price by 17.33%. The company’s shares are currently up 8.24% year-to-date, but still down -14.15% over the last five days. On the other hand, Vaxart Inc (NASDAQ:VXRT) is -20.87% down in the 30-day period. We can see from the shorts that 11.27 million shares have been sold at a short interest cover period of 11.71 day(s).

The consensus price target as assigned by Wall Street analysts is $2, which translates to bulls needing to increase their stock price by 69.0% from its current value. Analyst projections state that VXRT is forecast to be at a low of $2 and a high of $2.

Vaxart Inc (VXRT) estimates and forecasts

Vaxart Inc share prices are performing particularly well compared to other companies within the same industry. As is evident from the statistics, the company’s shares have fallen -27.90 percent over the past six months and at a 24.56% annual growth rate that is well above the industry average of 16.10%. Moreover, analysts have decided to roll up on their fiscal year 2024 revenue estimates. The rating firms predict that it will gain 8.33% in revenue this quarter, and will report an increase of 14.29% in the next quarter. The year-over-year growth rate is expected to be 364.62%, up from the previous year.

Consensus estimates provided by 4 financial analysts predict the company will bring in an average of 15.68M in revenue for the current quarter. 3 analysts expect Vaxart Inc to make 8.32M in revenue for the current ending quarter. The company’s sales for the same quarters a year ago were 3.25M and 2.18M respectively. Analysts predict that the company’s current quarter sales will jump, forecast at 383.34%. Forecasts for the next quarter put sales growth at 281.71%.

Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 27.81%.

VXRT Dividends

Vaxart Inc’s next quarterly earnings report is expected to be released in December.

Vaxart Inc (NASDAQ:VXRT)’s Major holders

Upon looking at major shareholders, it appears that insiders hold 0.87% of Vaxart Inc shares, and 17.80% of them are in the hands of institutional investors. The stock currently has a share float of 17.96%. Vaxart Inc stock is held by 119.0 institutions, with SIO CAPITAL MANAGEMENT, LLC being the largest institutional investor. By 2024-06-30, it held 8.7465% of the shares, which is about 14.76 million shares worth $9.85 million.

VANGUARD GROUP INC, with 5.8947% or 9.95 million shares worth $6.64 million as of 2024-06-30, holds the second largest percentage of outstanding shares.